MX2014001383A - Colageno 7 y metodos relacionados. - Google Patents

Colageno 7 y metodos relacionados.

Info

Publication number
MX2014001383A
MX2014001383A MX2014001383A MX2014001383A MX2014001383A MX 2014001383 A MX2014001383 A MX 2014001383A MX 2014001383 A MX2014001383 A MX 2014001383A MX 2014001383 A MX2014001383 A MX 2014001383A MX 2014001383 A MX2014001383 A MX 2014001383A
Authority
MX
Mexico
Prior art keywords
collagen
related methods
functional fragments
methods
well
Prior art date
Application number
MX2014001383A
Other languages
English (en)
Other versions
MX351565B (es
Inventor
Mark De Souza
Malini Viswanathan
Original Assignee
Lotus Tissue Repair Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lotus Tissue Repair Inc filed Critical Lotus Tissue Repair Inc
Publication of MX2014001383A publication Critical patent/MX2014001383A/es
Publication of MX351565B publication Critical patent/MX351565B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13—Dipeptidases (3.4.13)
    • C12Y304/13009—Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485—Exopeptidases (3.4.11-3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase

Abstract

Se describen los métodos para elaborar el colágeno 7, o los fragmentos funcionales del mismo, así como el colágeno 7, y los fragmentos funcionales del mismo producidos por medio de tales métodos, los ácidos nucleicos que codifican el colágeno 7, y los fragmentos funcionales del mismo, así como los vectores y las células hospedadoras que comprenden tales ácidos nucleicos.
MX2014001383A 2011-08-03 2012-08-03 Colageno 7 y metodos relacionados. MX351565B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161514796P 2011-08-03 2011-08-03
PCT/US2012/049553 WO2013020064A1 (en) 2011-08-03 2012-08-03 Collagen 7 and related methods

Publications (2)

Publication Number Publication Date
MX2014001383A true MX2014001383A (es) 2014-08-26
MX351565B MX351565B (es) 2017-10-19

Family

ID=47629706

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001383A MX351565B (es) 2011-08-03 2012-08-03 Colageno 7 y metodos relacionados.

Country Status (10)

Country Link
US (1) US9676837B2 (es)
EP (1) EP2753704A4 (es)
JP (2) JP2014524241A (es)
KR (1) KR20140054160A (es)
CN (2) CN108165593A (es)
AU (2) AU2012289916B2 (es)
BR (1) BR112014002546A2 (es)
CA (1) CA2843896A1 (es)
MX (1) MX351565B (es)
WO (1) WO2013020064A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60138535D1 (de) 2000-02-04 2009-06-10 Children S Hospital Res Founda Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
FI3205351T3 (fi) 2010-04-23 2023-07-06 Alexion Pharma Inc Lysosomaalisen kertymätaudin entsyymi
NZ608292A (en) 2010-09-09 2014-10-31 Synageva Biopharma Corp Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
EP2675472A4 (en) 2011-02-15 2014-09-17 Synageva Biopharma Corp METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE
EP2701508A4 (en) 2011-04-26 2015-01-07 Univ Leland Stanford Junior MANUFACTURE AND DELIVERY OF A STABLE COLLAGEN
MX2016009771A (es) 2014-01-31 2016-11-14 Factor Bioscience Inc Metodos y productos para la produccion y administracion de acido nucleico.
WO2015157469A2 (en) 2014-04-08 2015-10-15 University Of Southern California Polypeptide compositions with type vii collagen fibronectin type iii- like repeats and treatment methods for wound closure and healing
KR102204367B1 (ko) * 2014-07-16 2021-01-19 주식회사 엘지생활건강 피부 주름 개선용 화장료 조성물
AU2016218977C1 (en) 2015-02-13 2023-03-23 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
WO2017160636A1 (en) * 2016-03-16 2017-09-21 Shire Human Genetic Therapies, Inc. Methods of purifying collagen 7
CA3033788A1 (en) 2016-08-17 2018-02-22 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
US11028146B2 (en) * 2017-09-22 2021-06-08 Modern Meadow, Inc. Recombinant yeast strains
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN109022464A (zh) * 2018-07-02 2018-12-18 西安巨子生物基因技术股份有限公司 重组人源型胶原蛋白的羟基化方法
JP2022527082A (ja) * 2019-03-27 2022-05-30 フェニックス ティシュー リペア インコーポレイテッド コラーゲン７組成物を産生するための系および方法
SG11202111349QA (en) 2019-04-12 2021-11-29 Geltor Inc Recombinant elastin and production thereof
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
TW202134267A (zh) 2020-01-24 2021-09-16 美商格爾托公司 無動物成分之膳食膠原蛋白
CA3234797A1 (en) 2021-10-12 2023-04-20 Hal Landy Collagen 7 protein replacement therapy
CN117143223B (zh) * 2022-08-23 2024-03-08 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
WO2001009318A1 (fr) 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
US7026463B2 (en) * 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
CA2388477C (en) 1999-11-12 2014-01-21 Fibrogen, Inc. Recombinant gelatins with uniform molecular weight
CN1552889A (zh) * 2003-12-18 2004-12-08 四川铭让生物科技有限公司 制备胶原蛋白和胶原多肽的方法及其用途
JP4490498B2 (ja) 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
EP2701508A4 (en) * 2011-04-26 2015-01-07 Univ Leland Stanford Junior MANUFACTURE AND DELIVERY OF A STABLE COLLAGEN

Also Published As

Publication number Publication date
BR112014002546A2 (pt) 2017-03-14
EP2753704A1 (en) 2014-07-16
EP2753704A4 (en) 2015-07-08
CN103842517A (zh) 2014-06-04
KR20140054160A (ko) 2014-05-08
WO2013020064A1 (en) 2013-02-07
CA2843896A1 (en) 2013-02-07
US20150011733A1 (en) 2015-01-08
MX351565B (es) 2017-10-19
AU2012289916B2 (en) 2017-08-03
JP2017209117A (ja) 2017-11-30
CN108165593A (zh) 2018-06-15
AU2012289916A1 (en) 2014-02-20
JP2014524241A (ja) 2014-09-22
US9676837B2 (en) 2017-06-13
AU2017254910A1 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
MX2014001383A (es) Colageno 7 y metodos relacionados.
IN2014CN04586A (es)
MX2013007853A (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
MX2013007997A (es) Polipeptidos que tienen actividad de incremento celulolitico y polinucleotidos que codifican para los mismos.
MX337919B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
EP3741849A3 (en) Protease variants and polynucleotides encoding same
MX2012007710A (es) Alfa-amilasas.
MX2013004892A (es) Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos.
MX2015008446A (es) Composiciones de proteinas de union multivalentes.
MX2015000312A (es) Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican.
MX337913B (es) Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos.
MX346923B (es) Genes y proteinas para sintesis de alcanoil-coa.
EP3805348A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
TN2014000360A1 (en) Cx3cr1-binding polypeptides
MX2014004598A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
EP4253534A3 (en) Alpha-amylase variants and polynucleotides encoding same
EP3696265A3 (en) Lipase variants and polynucleotides encoding same
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
MX363261B (es) Polipéptidos que tienen actividad de la fosfolipasa a y polinucleótidos que los codifican.
MX2014001594A (es) Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican.
WO2012136898A3 (en) Novel cutinases, their production and uses
IN2015DN03206A (es)
MX350391B (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
MX2014007446A (es) Variantes de subtilasa y polinucleotidos que las codifican.
MX2015007775A (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: PHOENIX TISSUE REPAIR, INC.